Bioactivity:

Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing

CAS nr:

223488-57-1

Purity:

98%

Molecular Weight:

468,57

SMILES:

O=C(O)COC1=CC=CC(CN(CC2=CC=C(C(C)(C)C)C=C2)S(=O)(C3=CC=CN=C3)=O)=C1

Formula:

C25H28N2O5S

Pathway:

GPCR/G Protein,Immunology/Inflammation

Target:

Prostaglandin Receptor,Prostaglandin Receptor